About Glycologix
Glycologix is a private company based in Beverly, Massachusetts, incorporated in 2021 in Delaware. It has reported $5,200,687 raised in four offerings on Form D since January 2022. Its chief executive is Daniel Deardorf.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 12, 2025 | Dec 29, 2025 | $800,000of $1.0M target | 30 | $26,667 | Equity, DebtRule 506(b) | Form D ↗ |
| Apr 5, 2024 | Apr 9, 2024 | $1,500,000fully sold | 48 | $31,250 | EquityRule 506(b) | Form D ↗ |
| May 15, 2023 | May 23, 2023 | $1,100,687of $1.7M target | 25 | $44,027 | EquityRule 506(b) | Form D ↗ |
| Dec 24, 2021 | Jan 10, 2022 | $1,800,000of $3.0M target | 28 | $64,286 | Equity, DebtRule 506(b) | Form D ↗ |
| Total, four offerings | $5,200,687 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Glycologix's Form D filed Dec 29, 2025.
GA
George Adaniya
Director
DD
Daniel Deardorf
Chief Executive Officer and director
MF
Martha Farmer
Director
MM
MC
Michael Chester
Director
Earlier filings also listed Douglas Smith (executive officer, last listed Apr 2024).